Syndax Pharmaceuticals Inc (SNDX) — Capital Reinvestment Ratio
Syndax Pharmaceuticals Inc (SNDX) has a Capital Reinvestment Ratio of 0.00x as of December 2021, meaning it reinvests 0% of its operating cash flow ($100.71 Million) in capital expenditures ($129.00K). Check tangible equity quality of Syndax Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Syndax Pharmaceuticals Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Syndax Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see how efficiently does Syndax Pharmaceuticals Inc generate cash.
Annual Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Syndax Pharmaceuticals Inc from 2021 to 2021. See Syndax Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $29.13 Million | $129.00K | — |